Indigo Biosciences inks $500K
Indigo Biosciences, a Pennsylvania-based provider of nuclear receptor-focused products and services, has closed $500,000 in Series B funding. The Life Sciences Greenhouse of Central Pennsylvania and AGSM were the lead investors.
3 August 2016•1 min read
